Mark Manning

Dr. Mark Manning is Chief Scientific Officer, Legacy BioDesign, LLC. Manning has been involved in the development of biopharmaceutical products since 1988, when he joined the faculty at the University of Kansas. He then moved to the University of Colorado, where he helped found the Center for Pharmaceutical Biotechnology, widely considered to be the leading educational program in the country for training formulation scientists to handle biotechnology-based products. Manning has consulted for more than 40 companies on a wide variety of projects. In addition, he has directed numerous formulation development projects for clients, first as Chief Technical Officer for HTD BioSystems and then as Chief Scientific Officer for Legacy BioDesign. Manning has published over 100 scientific articles, holds five U.S. patents, and has edited three books on protein formulation. Manning received an A.B. degree in chemistry from Hope College and his M.S. and Ph.D. degrees from Northwestern University. He conducted post-doctoral work at Colorado State University.